Skip to main content
. 2020 Oct 28;9(11):2368. doi: 10.3390/cells9112368

Table 1.

Rare functional variants identified by Sanger and targeted analysis of whole exome sequencing data for the PRRT2, PNKD, SLC1A3, SLC2A1, SLC4A4, and ATP1A4 genes in 187 patients referred for genetic testing for hemiplegic migraine, but negative for mutations in CACNA1A, ATP1A2, and SCN1A.

Gene Patient ID# Locus Transcript Coding Protein Change dbSNP MAF gnomAD (No. Alleles) MAF gnomAD Eur NF (No. Alleles) ClinVar (or LOVD) Annotation SIFT a Polyphen2 b Mutation Taster c Conservation d
PhylopP/
PhastCons
PRRT2 224
225
chr16:29824442 NM_145239.3 c.67G>A p.Glu23Lys rs140383655 0.0011 (306) 0.0017 (219) LB, VUS T B P 0.01/0.68
185
201
211
227
chr16:29825022 NM_145239.3 c.647C>T p.Pro216Leu rs76335820 0.007 (1737) 0.010 (1183) B, LB D D D 3.75/0.99
433 chr16:29825025 NM_145239.3 c.650G>A p.Arg217Gln rs75497546 0.000008 (2) 0.0000092 (1) D D P 1.94/0.75
137 chr16:29825762 NM_145239.3 c.988G>A p.Ala330Thr rs757132796 0.0000042 (1) 0.0000092 (1) D PD D 2.77/1
261 chr16:29825888 NM_001256442 c.1114C>T p.Leu372Phe rs565298585 0.000046 (13) 0.0001 (13) D B P 0.07/0.99
PNKD 32 chr2:219209684 NM_015488.5 c.1140_1145delTATGCA p.Met381_His382del rs576363906 0.00061 (170) 0.0010 (135) LB N/A N/A P N/A
SLC1A3 135
155
159
196
chr5:36677083 NM_004172.5 c.657G>C p.Glu219Asp rs2032892 0.023 (6697) 0.0069 (887) B, LB T B P
107 chr5:36680556 NM_004172.5 c.1154G>A p.Arg385His rs115702388 0.00026 (74) 0.000061 (8) B, LB D D D 6.24/0.998
SLC2A1 109 chr1:43396789 NM_006516.2 c.203C>T p.Ser68Leu 0 0 VUS D B D 3.79/0.997
189 chr1:43394924 NM_006516.2 c.929C>T p.Thr310Ile rs80359824 0 0 D D D 3.47/1
179 chr1:43394873 NM_006516.2 c.972+7del (intronic) p.Leu232PhefsTer? rs531385270 0.00018 (52) 0.00038 (50) B, LB, VUS N/A N/A D 1.22/0.62
SLC4A4 136 chr4:72205146 NM_001098484.3 c.313C>G p.Pro105Ala rs768913941 0.000056 (16) 0.000092 (12) D B/PD D 6.09/1
142 chr4:72306423 NM_001098484.3 c.898A>G p.Ile300Val rs747159754 0.000053 (15) 0.00010 (11) T B D 1.72/1
237 chr4:72316925 NM_001098484.3 c.1229G>A p.Gly410Glu 0 0 T B D 5.76/1
120
179
chr4:72338589 NM_001098484.3 c.1805A>G p.Lys602Arg rs72650362 0.0022 (609) 0.0035 (455) D D D 5.00/1
202
232
chr4:72363294 NM_001098484.3 c.2051A>T p.Asn684Ile rs35891845 0.0016 (443) 0.0029 (368) T B D 2.58/1
128 chr4:72399974 NM_001098484.3 c.2311C>T p.Pro771Ser rs140882617 0.0014 (414) 0.0017 (231) VUS T B D 2.55/1
150 chr4:72412109 NM_001098484.3 c.2485C>A p.Leu829Ile rs201643562 0.00036 (103) 0.00056 (72) VUS D D D 4.27/1
ATP1A3 165 chr19:42474557 NM_152296.5 c.2401G>A p.Asp801Asn rs80356537 0 0 Pathogenic for AHC2 D D D 4.83/1
87 chr19:42474436 NM_152296.5 c.2443G>A p.Glu815Lys rs387907281 0 0 Pathogenic for AHC2 D D D 4.77/1
ATP1A4 228 chr1:160123000 NM_144699.4 c.193G>A p.Val65Met rs7549352 0.00087 (246) 0.0015 (194) D PD D 2.14/0.95
150 chr1:160125005 NM_144699.4 c.378G>T p.Gln126His rs370755520 0.0013 (364) 0 D B D 2.46/0.93
161
186
chr1:160125859 NM_144699.4 c.436G>A p.Val146Ile rs41288133 0.0022 (623) 0.0041 (539) T B P 0.322/0
186 chr1:160129260 NM_144699.4 c.722A>G p.His241Arg rs151137285 0.0005 (140) 0.0010 (129) D B D 4.453/1
189 chr1:160133954 NM_144699.4 c.787C>T p.Arg263Trp rs146761116 0.00037 (105) 0.00063 (81) D D P 1.41/0.95
133
144
204
chr1:160133955 NM_144699.4 c.788G>A p.Arg263Gln rs76528638 0.014 (3969) 0.0012 (159) T B P 0.83/0.92
141
188
chr1:160134012 NM_144699.4 c.845C>T p.Thr282Met rs144463520 0.001 (307) 0.0020 (268) D D D 5.19/1
92 chr1:160136403 NM_144699.4 c.1133C>T p.Thr378Met rs150693480 0.000045 (13) 0.000061 (8) D D D 5.09/1
90 chr1:160136459 NM_144699.4 c.1189G>A p.Ala397Thr rs147875149 0.000050 (14) 0.0000077 (1) D D D 1.84/1
144 chr1:160141171 NM_144699.4 c.1622T>G p.Met541Arg rs16831482 0.000004 (1) 0.0000087 (1) D PD D 1.63/0.87
144 chr1:160141525 NM_144699.4 c.1832A>G p.Lys611Arg rs79938119 0.0041 (1180) 0.000061 (4) B, VUS (LOVD) D D D 2.64/1
96 chr1:160143962 NM_144699.4 c.2053G>C p.Asp685His rs144428770 0.00081 (228) 0.0016 (207) D D D 3.49/0.96
124 chr1:160146341 NM_144699.4 c.2539A>T p.Thr847Ser rs145873902 0.00016 (45) 0.00026 (34) T B P 1.38/0.86

ID#, identification number; HM, hemiplegic migraine; dbSNP, Single Nucleotide Polymorphism Database; MAF gnomAD, minor allele frequency in The Genome Aggregation Database (gnomAD); Eur NF, European Non-Finnish; LOVD, Leiden Open Variation Database v3.0; AHC2, alternating hemiplegia of childhood 2. a Sorting Intolerant from Tolerant (SIFT) variant pathogenicity prediction tool: D, damaging; T, tolerated. b Polymorphism Phenotyping v2 (Polyphen2) variant pathogenicity prediction tool: D, probably damaging; PD, possibly damaging; B, benign. c Mutation Taster variant pathogenicity prediction tool: D, disease-causing; P, polymorphism. d Nucleotide conservation scores derived from: PhyloP, values between 0 and 1, 1 high conservation; PhastCons, values between −14 and +6, >2 high, >4.88 very high conservation.